Position in NUVB
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,685,909
-$6,161,276 QoQ
Shares Held
392,986
-55.1% QoQ
Ownership
0.113%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NUVB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026D. E. Shaw & Co., Inc. holds $4,371,472,260 across 180 Biotechnology names. NUVB ranks #125 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
5,625,825 | $919,934,903 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,059,062 | $350,411,843 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
2,545,486 | $189,027,789 | |
| 4 | PCVX |
Vaxcyte, Inc.
|
2,865,318 | $166,503,628 | |
| 5 | EXEL |
Exelixis, Inc.
|
3,603,063 | $154,535,371 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
1,868,708 | $120,774,597 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
1,640,381 | $111,759,157 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
248,960 | $111,170,598 |
All Filings in NUVB
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,685,909 | 392,986 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $7,847,185 | 875,802 | Shares | Defined | 2026-02-17 | |
| 2025-03-31 | $21,296 | 12,100 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $126,084 | 47,400 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $254,709 | 111,227 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $501,641 | 171,795 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $3,133,821 | 860,940 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $777,543 | 514,930 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $91,080 | 67,971 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $202,024 | 112,236 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $132,303 | 79,701 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $227,080 | 118,271 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $490,168 | 218,825 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $478,596 | 147,715 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $172,412 | 32,778 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $594,745 | 69,970 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,644,980 | 165,491 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,572,598 | 168,915 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||